Cite
MLA Citation
Egbert F Smit and Adrianus J de Langen. “Pembrolizumab for all PD-L1-positive NSCLC.” Lancet, vol. 393, no. 10183, 2019, pp. 1776–1778. http://access.bl.uk/ark:/81055/vdc_100081476082.0x000052
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Egbert F Smit and Adrianus J de Langen. “Pembrolizumab for all PD-L1-positive NSCLC.” Lancet, vol. 393, no. 10183, 2019, pp. 1776–1778. http://access.bl.uk/ark:/81055/vdc_100081476082.0x000052